Keros Therapeutics, Inc. · NASDAQ:KROS

D. E. Shaw & Co., L.P.'s stake in Keros Therapeutics, Inc. fell to 3.90% (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 17, 2026

D. E. Shaw & Co., L.P.'s stake in Keros Therapeutics, Inc. fell to 3.90%, 756,156 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).

Stake
3.90%
Shares
756,156
Intent
Passive
What changed
Fell below 5%
Filed together
3 holders

The filing in full

HolderStakeShares
D. E. Shaw & Co., L.P.3.90%756,156
D. E. Shaw & Co., L.L.C.3.90%755,473
David E. Shaw3.90%756,156

Source

View original at SEC

Related